Tara Bancroft
Stock Analyst at TD Cowen
(4.73)
# 659
Out of 4,362 analysts
267
Total ratings
47.9%
Success rate
22.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| URGN UroGen Pharma | Maintained: Buy | $35 | $26.60 | +31.58% | 21 | May 15, 2026 | |
| CELC Celcuity | Maintained: Buy | n/a | $88.95 | - | 13 | May 14, 2026 | |
| STRO Sutro Biopharma | Maintained: Buy | n/a | $27.18 | - | 12 | May 14, 2026 | |
| FATE Fate Therapeutics | Maintained: Hold | n/a | $2.22 | - | 13 | May 13, 2026 | |
| XNCR Xencor | Maintained: Buy | n/a | $11.42 | - | 12 | May 11, 2026 | |
| RCKT Rocket Pharmaceuticals | Maintained: Hold | n/a | $2.92 | - | 2 | May 10, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $85 → $105 | $100.25 | +4.74% | 19 | May 7, 2026 | |
| WHWK Whitehawk Therapeutics | Maintained: Hold | n/a | $4.35 | - | 12 | May 7, 2026 | |
| GERN Geron | Maintained: Buy | $3 | $1.16 | +158.62% | 19 | May 6, 2026 | |
| EYPT EyePoint | Maintained: Buy | $20 | $12.34 | +62.07% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $40.11 | +24.66% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 | $46.93 | +59.81% | 15 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $25.06 | - | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $8.35 | +139.52% | 23 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $95.41 | +4.81% | 15 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $70.35 | - | 12 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $4.20 | - | 12 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $35.07 | - | 3 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $0.9737 | - | 11 | Mar 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.20 | - | 14 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20.00 | $12.20 | +63.93% | 16 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.03 | n/a | 2 | Mar 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.45 | n/a | 3 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $17.98 | n/a | 2 | Jul 26, 2024 |
UroGen Pharma
May 15, 2026
Maintained: Buy
Price Target: $35
Current: $26.60
Upside: +31.58%
Celcuity
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $88.95
Upside: -
Sutro Biopharma
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $27.18
Upside: -
Fate Therapeutics
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $2.22
Upside: -
Xencor
May 11, 2026
Maintained: Buy
Price Target: n/a
Current: $11.42
Upside: -
Rocket Pharmaceuticals
May 10, 2026
Maintained: Hold
Price Target: n/a
Current: $2.92
Upside: -
Lantheus Holdings
May 7, 2026
Maintained: Buy
Price Target: $85 → $105
Current: $100.25
Upside: +4.74%
Whitehawk Therapeutics
May 7, 2026
Maintained: Hold
Price Target: n/a
Current: $4.35
Upside: -
Geron
May 6, 2026
Maintained: Buy
Price Target: $3
Current: $1.16
Upside: +158.62%
EyePoint
May 6, 2026
Maintained: Buy
Price Target: $20
Current: $12.34
Upside: +62.07%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $40.11
Upside: +24.66%
May 6, 2026
Maintained: Buy
Price Target: $75
Current: $46.93
Upside: +59.81%
May 6, 2026
Maintained: Buy
Price Target: n/a
Current: $25.06
Upside: -
May 5, 2026
Maintained: Buy
Price Target: $20
Current: $8.35
Upside: +139.52%
May 5, 2026
Maintained: Buy
Price Target: $100
Current: $95.41
Upside: +4.81%
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $70.35
Upside: -
Apr 30, 2026
Maintained: Buy
Price Target: n/a
Current: $4.20
Upside: -
Apr 1, 2026
Maintained: Buy
Price Target: n/a
Current: $35.07
Upside: -
Mar 11, 2026
Maintained: Buy
Price Target: n/a
Current: $0.9737
Upside: -
Mar 10, 2026
Rated: Hold
Price Target: n/a
Current: $4.20
Upside: -
Feb 19, 2026
Maintained: Buy
Price Target: $20.00
Current: $12.20
Upside: +63.93%
Mar 14, 2025
Rated: Hold
Price Target: n/a
Current: $2.03
Upside: n/a
Aug 9, 2024
Rated: Buy
Price Target: n/a
Current: $5.45
Upside: n/a
Jul 26, 2024
Downgraded: Hold
Price Target: n/a
Current: $17.98
Upside: n/a